Patent details

Basic Information

Publication number:

EP2379072

PCT Application Number:

PCT/US/2009/051511

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP098118987

PCT Publication Number:

WO/2010/027572

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

REDUCING CHOLESTEROL LEVELS WITH COMBINED USE OF QUERCETING AND STATIN

French Title of Invention:

UTILISATION COMBINÉE DE QUERCÉTINE ET DE STATINES POUR RÉDUIRE DES TAUX DE CHOLESTÉROL

German Title of Invention:

SENKUNG DES CHOLESTERINSPIEGELS MIT KOMBINIERTER ANWENDUNG VON QUERCETIN UND STATIN

SPC Number:

Dates

Filing date:

23/07/2009

Grant date:

08/04/2015

EP Publication Date:

08/04/2015

PCT Publication Date:

11/03/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/10/2011

EP B1 Publication Date:

08/04/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

23/07/2017

Expiration date:

23/07/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/05/2015

 

 

Name:

Quercegen Pharmaceuticals LLC

Address:

225 Cedar Hill Street, Suite 200, Marlborough, MA 01752, United States (US)

Agent

Name:

VALIPAT

From:

01/07/2015

Address:

Uitbreidingstraat 72-5, 2600, Antwerp, Belgium (BE)

To:

Inventor

Name:

LINES Thomas, Christian

Address:

United States (US)

Priority

Priority Number:

205070

Priority Date:

05/09/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/352;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

26/07/2016

Last Annual Fee Paid Number:

8

Last Annual Fee Paid Amount:

99 Euro

Payer:

OFFICE FREYLINGER S.A.

Filing date	Document type	Number of pages